← Insider buys
ALLO

Allogene Therapeutics, Inc. · Healthcare

Chief Technical Officer Alison Moore sold $1.4M of Allogene Therapeutics, Inc.

Sold$1,437,603
$29.44Price
48,827Shares
−43%Stake

What ALLO did after the filing

Prices for ALLO after this filing aren't in yet.

Traded Fri, Jul 26. Filed Tue, Jul 30, 2:23 PM ET, during the session. Not investment advice.